Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple glue stop Post-Surgery fluid pockets in breast cancer patients?

NCT ID NCT01742975

Symptom relief Sponsor: Hôpital Européen Marseille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a surgical glue called Ifabond can reduce seroma—painful fluid collections—after breast cancer surgery. 104 women having partial mastectomy with or without lymph node removal were randomly assigned to receive standard surgery plus the glue or standard surgery alone. The main goal was to measure fluid volume and ultrasound findings at 15 and 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ifabond (surgical glue)
What this could lead to
If it works, this could reduce painful fluid collections after breast cancer surgery, lowering the need for needle drainage and improving comfort.
What could go wrong
This is a small, completed study with 104 patients. The glue may not significantly reduce seroma, and some people may be allergic to cyanoacrylate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

104 people

The number who actually took part.

Start date

Nov 2011

Finished

Feb 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * "Eastern Cooperative Oncology Group" ECOG status ≤ 2 * Diagnosis of invasive or In situ breast cancer * Patient undergoing partial mastectomy with or without axillary lymph node dissection,(without communication between the two surgical loges) Exclusion Criteria: * Pregnant or breast-feeding patient * Participation at another protocol with an Investigational drug (within the last 4 weeks before enrollment) * Known hypersensitivity to Cyanoacrylate * Known hypersensitivity to formaldehyde * Patient who experience systemic infections preoperatively, or have conditions that are known to interfere with the healing process * Patient with uncontrolled diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm lymphocele

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Lymphocele

Contacts and locations

Locations

  • Centre de Chirurgie Gynecologique Et Des Maladies Du Sein

    Grenoble, Auvergne-Rhône-Alpes, 38000, France

  • Hôpital Euroépen Marseille

    Marseille, PACA, 13003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.